(Press-News.org) In contrast to previous preliminary data, use of vitamin E or the diabetes drug metformin was not superior to placebo on a measured outcome for treating nonalcoholic fatty liver disease in children and adolescents, according to a study in the April 27 issue of JAMA.
"Coincident with the rise in prevalence of childhood and adolescent obesity over the past few decades, nonalcoholic fatty liver disease (NAFLD) has become the most common cause of chronic liver disease in children in the United States," according to background information in the article. NAFLD encompasses a range of severity, from mild to severe disease that may ultimately result in advanced fibrosis (development of excess fibrous connective tissue in an organ), cirrhosis, and liver cancer. Insulin resistance is frequently identified in both adults and children with NAFLD, and treatment approaches to NAFLD target reduction in insulin resistance and oxidative stress. Pediatric pilot data demonstrated potential efficacy of metformin or vitamin E in treating NAFLD.
Joel E. Lavine, M.D., Ph.D., of Columbia University, New York, and colleagues conducted a randomized-controlled trial evaluating vitamin E or metformin for the treatment of NAFLD in children. The study, conducted at 10 university clinical research centers between September 2005 and March 2010, included 173 patients (ages 8-17 years) with biopsy-confirmed NAFLD. Patients received daily dosing of 800 IU of vitamin E (58 patients), 1000 mg of metformin (57 patients), or placebo (58 patients) for 96 weeks. The predefined primary outcome measure for this trial was sustained reduction in alanine aminotransferase (ALT; an enzyme which is significantly associated with NAFLD activity score and fibrosis stage in children) defined as 50 percent or less of the baseline level or 40 U/L or less at visits every 12 weeks from 48 to 96 weeks of treatment.
The researchers found that the attainment of sustained reduction in ALT level was similar to placebo (10/58; 17 percent) in both the vitamin E (15/58; 26 percent) and metformin treatment groups (9/57; 16 percent). The average change in ALT level from baseline to 96 weeks was -35.2 U/L in the placebo group vs. -48.3 U/L in the vitamin E group and -41.7 U/L in the metformin group.
Among the 121 patients who had either NASH (nonalcoholic steatohepatitis; fatty inflammation of the liver) or borderline NASH at baseline, the resolution of NASH was significantly greater in children treated with vitamin E than with placebo (58 percent vs. 28 percent). Differences between treatment groups in terms of frequency or severity of adverse events were not significant.
"In summary, this double-blind, placebo-controlled, randomized trial of metformin or vitamin E for the treatment of NAFLD in children without diabetes or cirrhosis had a negative primary outcome. The data suggest that children treated with vitamin E who had biopsy-proven NASH or borderline NASH had significant improvement in secondary histologic outcomes with vitamin E."
"However, risk of biopsy might outweigh the benefits of therapy, so development of noninvasive markers for identification and monitoring of those who may benefit is desirable. Lifestyle modification is warranted for all children with NAFLD. The role of treatment with vitamin E in those who have a biopsy demonstrating borderline or definite NASH remains to be determined," the authors conclude.
###
(JAMA. 2011;305[16]1659-1668. Available pre-embargo to the media at www.jamamedia.org)
Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
To contact Joel E. Lavine, M.D., Ph.D., call Alex Lyda at 212-305-0820 or email alyda@columbia.edu.
For more information, contact JAMA/Archives Media Relations at 312/464-JAMA (5262) or e-mail mediarelations@jama-archives.org.
Vitamin E or metformin may not be effective for treating liver disease in children and teens
2011-04-27
ELSE PRESS RELEASES FROM THIS DATE:
Celebrate Mother's Day at Chef Point Cafe
2011-04-27
This Mother's Day, Fort Worth restaurant, Chef Point Cafe, is giving moms a real treat with a special menu devoted to this holiday. This day, dedicated to matriarchs, is for enjoying family and what better way to do that then with a fabulous meal in a fine dining restaurant renowned for world-class cuisine? Find out what Mother's Day means, then see how dining together over a special feast celebrates each doting mother who went above and beyond her maternal duties.
The tradition of honoring mothers on a particular day is traced back to ancient Grecian times. Modern etiquette ...
Medication nonadherence patterns among children with epilepsy associated with socioeconomic status
2011-04-27
An examination of medication adherence among children with newly diagnosed epilepsy found that nearly 60 percent showed persistent nonadherence during the first 6 months of therapy, and that lower socioeconomic status was associated with higher non-adherence, according to a study in the April 27 issue of JAMA.
Epilepsy, a disorder of recurrent unprovoked seizures, affects 325,000 children younger than 15 years in the United States. "Because of epilepsy's common occurrence, the narrow therapeutic and safety margins of antiepileptic medications, and the recognized complications ...
Low health literacy associated with higher rate of death among heart failure patients
2011-04-27
An examination of health literacy (such as understanding basic health information) among managed care patients with heart failure, a condition that requires self-management, found that nearly one in five have low health literacy, which was associated with a higher all-cause risk of death, according to a study in the April 27 issue of JAMA.
Health literacy is the degree to which individuals can obtain, process and understand basic health information and services needed to make appropriate health decisions, as defined by the Institute of Medicine. According to background ...
Increase in evidence-based treatments followed by decreased risk of death in heart attack patients
2011-04-27
In an analysis of data from a coronary care registry in Sweden, between 1996-2007 there was an increase in the prevalence of use of evidence-based invasive procedures and pharmacological therapies for treatment of a certain type of heart attack, and a decrease in the rate of death at 30 days and one year after a heart attack for these patients, according to a study in the April 27 issue of JAMA.
Although recent population-based studies indicate a reduction in incidence, ST-elevation myocardial infarction (STEMI; a certain pattern on an electrocardiogram following a heart ...
Activation of biomarker linked with improved survival among obese patients with colorectal cancer
2011-04-27
Among obese patients, activation of the protein biomarker CTNNB1 was associated with better colorectal cancer-specific survival and overall survival, whereas post-diagnosis physical activity was associated with better colorectal cancer-specific survival among patients negative for CTNNB1, according to a study in the April 27 issue of JAMA.
Activation of the WNT signaling pathway (a network of proteins known for their roles in cancer) and cadherin-associated protein beta-1 (CTNNB1; [beta-catenin]) plays a critical role in colorectal carcinogenesis. Accumulating evidence ...
Studies of mutated protein in Lou Gehrig’s disease reveal new paths for drug discovery
2011-04-27
PHILADELPHIA -- Several genes have been linked to ALS, with one of the most recent called FUS. Two new studies in PLoS Biology, one from the University of Pennsylvania School of Medicine, and the other from colleagues at Brandeis University, both examined FUS biology in yeast and found that defects in RNA biology may be central to how FUS contributes to ALS, or Lou Gehrig's disease. These findings point to new targets for developing drugs.
Proteins aggregate to form insoluble clumps in the brain and spinal cord of ALS patients. In some instances of ALS, the clumping ...
Teen sleep study adds to evidence of a 'neural fingerprint'
2011-04-27
PROVIDENCE, R.I. [Brown University] — Teens are rarely described as stable, so when something about their rapidly changing brains remains placidly unaltered, neuroscientists take notice. Such is the case in a new study of electroencephalography (EEG) readings gathered from dozens of teens while they slept. Despite the major neural overhaul underway during adolescence, most individuals maintained a unique and consistent pattern of underlying brain oscillations. The work lends a new level of support to the idea, already observed in adults, that people produce a kind of brainwave ...
Will minorities be left out of health care law provision?
2011-04-27
Hospitals and physician practices that form care-coordinating networks called "Accountable Care Organizations (ACOs)," under provisions of the new health-care law could reap cost-savings and other benefits. However, experts at Johns Hopkins and the University of Pennsylvania warn that such networks could potentially be designed to exclude minorities and widen disparities in health care.
In a commentary appearing in the April 27 issue of the Journal of the American Medical Association, a Johns Hopkins physician says that as a result of new provisions in the Patient Protection ...
Dr Isabel Driggers, of Coastal Kids Dental & Braces, Was Selected as the South Carolina Delegate for the American Academy of Pediatric Dentist (AAPD) 2011 Congressional Lobby Day
2011-04-27
Coastal Kids Dental & Braces is proud to announce that Dr. Isabel Driggers, Owner and Founder of Coastal Kids Dental & Braces, was selected as the South Carolina representative by the AAPD to attend the 2011 Congressional Lobby Day. This is the 2nd year that Dr. Isabel has attending the AAPD Lobby Day as the SC representative.
As part of the AAPD Congressional Lobby Day, Dr. Isabel visited Washington, DC and met with the offices of Senators Lindsey Graham and Jim DeMint and Congressmen Tim Scott and Jim Clyburn to discuss current issues in Pediatric Dentistry ...
Chandra finds new evidence on origin of supernovas
2011-04-27
Astronomers may now know the cause of an historic supernova explosion that is an important type of object for investigating dark energy in the universe. The discovery, made using NASA's Chandra X-ray Observatory, also provides strong evidence that a star can survive the explosive impact generated when a companion star goes supernova.
The new study examined the remnant of a supernova observed by the Danish astronomer Tycho Brahe in 1572. The object, dubbed Tycho for short, was formed by a Type Ia supernova, a category of stellar explosion useful in measuring astronomical ...